1.4.2 Antimotility drugs

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

6 library items in 1.4.2 Antimotility drugs

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

1: Gastro-intestinal system (remove) , 1.4 Acute diarrhoea (remove) , 1.4.2 Antimotility drugs (remove)

Sort by: Display summary:

Results 1 - 6 of 6

Result page:
Previous
|
1
|
Next

1.

MHRA consults on reclassification of Imodium Instants 12 tablet pack size from P to GSL

Source: MHRA,
Date published: 07/02/2012

Category:

1.4.2 Antimotility drugs | Gastroenterology | Law/ medical ethics/ litigation | Medicines and Healthcare products Regulatory Agency (MHRA) | OTC medicines

NeLM Area:

News

Link
2.

Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis

Source: DARE,
Date published: 21/07/2010

Category:

1.4.2 Antimotility drugs | Bacterial | Infection | Motility and visceral sensation | Travel medicine

NeLM Area:

Evidence > Disease Focused Reviews

DARE abstract
3.

Antimotility agents for chronic diarrhoea in people with HIV/AIDS

Source: Cochrane Library,
Date published: 02/12/2008

Category:

1.4.2 Antimotility drugs | Drug reviews | HIV Infection/AIDS | Motility and visceral sensation

NeLM Area:

Evidence > Drug Class Focused Reviews

Link
4.

Imodium Instants (loperamide) - Revised SPC

Source: Chemist and Druggist,
Date published: 28/10/2008

Category:

1.4.2 Antimotility drugs | Adverse Drug Reactions | Gastroenterology | Product Licence Changes

NeLM Area:

Other Library Updates > SPC Changes

Link to SPC
5.

Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis

Source: DARE,
Date published: 04/06/2008

Category:

1.4.2 Antimotility drugs | Children (2-11 years) | Motility and visceral sensation

NeLM Area:

Evidence > Drug Specific Reviews

DARE abstract

PLoS Medicine full text link (PDF)
6.

Request to reclassify Imodium (loperamide) from P to GSL for IBS indication

Source: MHRA,
Date published: 18/06/2007

Category:

1.4.2 Antimotility drugs | Irritable bowel syndrome | Product Licence Changes

NeLM Area:

News

Link

Results 1 - 6 of 6

Result page:
Previous
|
1
|
Next